Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AbZ-Pharma is a prominent German pharmaceutical company specializing in the development and distribution of generic medications. Based in Ulm, the company offers a broad portfolio of cost-effective therapeutic solutions across various medical fields, including oncology, neurology, and infectious diseases. As a subsidiary of the Teva Group, AbZ-Pharma leverages extensive manufacturing and distribution networks to provide high-quality, affordable healthcare options to the German market. Their product line includes well-known generics such as Fluconazol AbZ, used for treating fungal infections. The company focuses on maintaining high standards of quality while ensuring medication remains accessible to a wide patient population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluconazol Abz.